TP53 and urinary bladder cancer: Notably, the H3K27 demethylase KDM6A is frequently found mutated in bladder cancer, and its deficiency upregulates cytokines and chemokines in mouse tumor models, promoting M2 polarization of macrophages, and collaborates with p53 dysfunction to contribute to bladder cancer (17).